ADVERSE REACTIONS
An increased risk of the following serious adverse reactions has been associated with the use of oral contraceptives (see WARNINGS section):
°
° Cerebral hemorrhage thrombosis with or without embolism
° Cerebral thrombosis
° Arterial thromboembolism
°
°
°
° Myocardial infarction
°
There is evidence of an association between the following conditions and the use of oral contraceptives:
° Mesenteric thrombosis
° Retinal thrombosis
The following adverse reactions have been reported in patients receiving oral contraceptives and are believed to be drug-related:
° Nausea
° Change in weight (increase or decrease)
° Vomiting
° Change in cervical
° Gastrointestinal symptoms (such as abdominal cramps and bloating)
° Diminution in lactation when given immediately postpartum
° Breakthrough
° Cholestatic jaundice
° Spotting
°
° Change in menstrual flow
° Rash (allergic)
°
° Mental
° Temporary
° Reduced tolerance to
° Vaginal candidiasis
° Edema
° Change in corneal curvature (steepening)
°
° Intolerance to
° Breast changes: tenderness, enlargement, secretion
The following adverse reactions have been reported in users of oral contraceptives and the association has been neither confirmed nor refuted:
° Pre-menstrual syndrome
°
°
°
° Changes in appetite
°
° Cystitis-like syndrome
°
°
° Impaired
° Nervousness
° Hemolytic uremic syndrome
°
°
° Hirsutism
° Changes in libido
° Loss of scalp hair
°
°
° Budd-Chiari Syndrome
